Form 4: HealthLynked CEO Michael Dent Acquires Convertible Notes

Sentiment:

SEC Form 4 Filing


Michael Dent, CEO of HealthLynked Corp, reports the acquisition of convertible notes through a trust.

Summary

  • Michael Dent, the CEO, a director, and a 10% owner of HealthLynked Corp, filed a Form 4.
  • The form reports the purchase of 12% convertible notes by the Mary S. Dent Gifting Trust, for which Michael Dent serves as trustee.
  • On April 1, 2025, the trust purchased $20,000 worth of convertible notes, exercisable from April 1, 2025, to October 1, 2025, convertible into 869,565 shares of common stock at a price of $0.023 per share.
  • On April 9, 2025, the trust purchased an additional $100,000 worth of convertible notes, exercisable from April 9, 2025, to October 9, 2025, convertible into 4,347,826 shares of common stock at a price of $0.023 per share.
  • The notes are held indirectly through the Mary S. Dent Gifting Trust.

Sentiment

Score: 5

Explanation: The document is a neutral report of insider transactions. It doesn't inherently indicate positive or negative sentiment, but rather provides factual information.

Industry Context

This filing is a routine disclosure of insider transactions, common in the healthcare technology sector where HealthLynked operates. It provides transparency into the investment activities of key company personnel.

Comparison to Industry Standards

  • Insider transactions are common across publicly traded companies, including those in the healthcare technology sector.
  • Comparable companies like Teladoc Health or Cerner Corporation also have executives who periodically report their transactions in company stock or related securities.
  • The size and frequency of these transactions vary depending on the individual's compensation structure and investment strategy.

Stakeholder Impact

  • The purchase of convertible notes by the CEO's trust could be viewed positively by shareholders as it demonstrates confidence in the company's future.
  • However, the potential dilution from the conversion of these notes into common stock should be considered.

Key Dates

DateDescription
01/31/2006Date of the Mary S. Dent Gifting Trust
04/01/2025Date of first convertible note transaction ($20,000)
04/01/2025Date the first convertible note becomes exercisable
04/09/2025Date of second convertible note transaction ($100,000)
04/09/2025Date the second convertible note becomes exercisable
04/10/2025Date of Form 4 filing
10/01/2025Expiration date of the first convertible note
10/09/2025Expiration date of the second convertible note

Keywords

Form 4, Convertible Notes, HealthLynked Corp, Michael Dent, Beneficial Ownership, Securities

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.